Virtus LifeSci Financials

BBP Etf  USD 56.61  0.23  0.41%   
Financial data analysis helps to confirm if markets are presently mispricing Virtus LifeSci. We have analyzed twelve available drivers for Virtus LifeSci Biotech, which can be compared to its competition. Please use Virtus LifeSci price to earning, beta, as well as the relationship between the Beta and five year return to make a decision on whether Virtus LifeSci Biotech is priced fairly. The etf experiences a normal upward fluctuation. Check odds of Virtus LifeSci to be traded at $59.44 in 90 days. Key indicators impacting Virtus LifeSci's financial strength include:
Net Expense Ratio
0.0079
3 y Sharp Ratio
0.1
With this module, you can analyze Virtus financials for your investing period. You should be able to track the changes in Virtus LifeSci individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Virtus LifeSci Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Virtus LifeSci's financial statements are interrelated, with each one affecting the others. For example, an increase in Virtus LifeSci's assets may result in an increase in income on the income statement.
Evaluating Virtus LifeSci's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Virtus LifeSci's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Virtus LifeSci's relative financial performance

Chance Of Distress

Less than 9

 
100  
 
Zero
Low
Virtus LifeSci Biotech has less than 9 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Virtus LifeSci etf is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
More Info
The data published in Virtus LifeSci's official financial statements usually reflect Virtus LifeSci's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Virtus LifeSci Biotech. For example, before you start analyzing numbers published by Virtus accountants, it's critical to develop an understanding of what Virtus LifeSci's liquidity, profitability, and earnings quality are in the context of the Virtus space in which it operates.
Please note, the presentation of Virtus LifeSci's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Virtus LifeSci's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Virtus LifeSci's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Virtus LifeSci Biotech. Please utilize our Beneish M Score to check the likelihood of Virtus LifeSci's management manipulating its earnings.

Virtus LifeSci Company Summary

Virtus LifeSci competes with First Trust, Fidelity MSCI, Virtus LifeSci, VanEck Biotech, and ProShares Ultra. Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Virtus Lifesci is traded on NYSEARCA Exchange in the United States.
InstrumentUSA Etf View All
ExchangeNYSE ARCA Exchange
ISINUS26923G2021
CUSIP26923G202
RegionNorth America
Investment IssuerVirtus
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkNYSE Composite
PhoneNA
CurrencyUSD - US Dollar
You should never invest in Virtus LifeSci without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Virtus Etf, because this is throwing your money away. Analyzing the key information contained in Virtus LifeSci's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Virtus LifeSci Key Financial Ratios

Generally speaking, Virtus LifeSci's financial ratios allow both analysts and investors to convert raw data from Virtus LifeSci's financial statements into concise, actionable information that can be used to evaluate the performance of Virtus LifeSci over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Virtus LifeSci Biotech reports annually and quarterly.

Virtus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Virtus LifeSci's current stock value. Our valuation model uses many indicators to compare Virtus LifeSci value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Virtus LifeSci competition to find correlations between indicators driving Virtus LifeSci's intrinsic value. More Info.
Virtus LifeSci Biotech is fifth largest ETF in five year return as compared to similar ETFs. It is rated below average in net asset as compared to similar ETFs making up about  2,994,340  of Net Asset per Five Year Return. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Virtus LifeSci by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Virtus LifeSci's Etf . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Virtus LifeSci's earnings, one of the primary drivers of an investment's value.

Virtus LifeSci Biotech Systematic Risk

Virtus LifeSci's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Virtus LifeSci volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Virtus LifeSci Biotech correlated with the market. If Beta is less than 0 Virtus LifeSci generally moves in the opposite direction as compared to the market. If Virtus LifeSci Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Virtus LifeSci Biotech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Virtus LifeSci is generally in the same direction as the market. If Beta > 1 Virtus LifeSci moves generally in the same direction as, but more than the movement of the benchmark.

About Virtus LifeSci Financials

What exactly are Virtus LifeSci Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Virtus LifeSci's income statement, its balance sheet, and the statement of cash flows. Potential Virtus LifeSci investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Virtus LifeSci investors may use each financial statement separately, they are all related. The changes in Virtus LifeSci's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Virtus LifeSci's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Virtus LifeSci Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Virtus LifeSci is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Virtus has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Virtus LifeSci's financials are consistent with your investment objective using the following steps:
  • Review Virtus LifeSci's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Virtus LifeSci's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Virtus LifeSci's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Virtus LifeSci's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Virtus LifeSci Thematic Clasifications

Virtus LifeSci Biotech is part of several thematic ideas from Health Care ETFs to Sector ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas

Virtus LifeSci March 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Virtus LifeSci help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Virtus LifeSci Biotech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Virtus LifeSci Biotech based on widely used predictive technical indicators. In general, we focus on analyzing Virtus Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Virtus LifeSci's daily price indicators and compare them against related drivers.
When determining whether Virtus LifeSci Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Virtus Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Virtus Lifesci Biotech Etf. Highlighted below are key reports to facilitate an investment decision about Virtus Lifesci Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Virtus LifeSci Biotech. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the Virtus LifeSci Biotech information on this page should be used as a complementary analysis to other Virtus LifeSci's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for Virtus Etf analysis

When running Virtus LifeSci's price analysis, check to measure Virtus LifeSci's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virtus LifeSci is operating at the current time. Most of Virtus LifeSci's value examination focuses on studying past and present price action to predict the probability of Virtus LifeSci's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virtus LifeSci's price. Additionally, you may evaluate how the addition of Virtus LifeSci to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
The market value of Virtus LifeSci Biotech is measured differently than its book value, which is the value of Virtus that is recorded on the company's balance sheet. Investors also form their own opinion of Virtus LifeSci's value that differs from its market value or its book value, called intrinsic value, which is Virtus LifeSci's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Virtus LifeSci's market value can be influenced by many factors that don't directly affect Virtus LifeSci's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Virtus LifeSci's value and its price as these two are different measures arrived at by different means. Investors typically determine if Virtus LifeSci is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Virtus LifeSci's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.